Rockwell Medical Delivers Preliminary Full-Year 2025 Results Highlighting Year-Over-Year Revenue Growth To $69.5M, Improved Profitability, And $25M Cash Position

Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Highlights

• The Company expects net sales for the fourth quarter 2025 to be approximately $18.6 million. The Company expects net sales for the full-year 2025 to be approximately $69.5 million.
• The Company expects gross margin for the fourth quarter 2025 to be approximately 22%, up from 14% in the third quarter 2025.
• The Company expects to report cash flow from operations of approximately $2.3 million in the fourth quarter 2025, which represents the second cash flow positive quarter in 2025. As a result, cash and cash equivalents and investments available-for-sale at December 31, 2025 are expected to increase to approximately $25 million.